computer‐generated list (program random) (ALTANA Inc)
Structured Review
Computer‐Generated List (Program Random), supplied by ALTANA Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/randomised+sequences/randomisation+sequence/pmc11365589-1690-34-44
Average 90 stars, based on 1 article reviews
Images
Related Articles
Biomarker Discovery:Article Title: A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. Article Snippet: Pharmacoeconomics 2007; 25 (8): 695-711ORIGINAL RESEARCH ARTICLE 1170-7690/07/0008-0695/$44.95/0 © 2007 Adis Data Information BV.. All rights reserved.. A 1-Year Prospective Generated:Article Title: A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. Article Snippet: Pharmacoeconomics 2007; 25 (8): 695-711ORIGINAL RESEARCH ARTICLE 1170-7690/07/0008-0695/$44.95/0 © 2007 Adis Data Information BV.. All rights reserved.. A 1-Year Prospective Article Title: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease Article Snippet: Randomised? , Low risk , "Treatment was assigned by the investigators with sequential study numbers according to a block randomisation list in ratios of 2:2:1 (Roflumilast 250 μg, Roflumilast 500 μg, Placebo).". .. Method of randomisation described? , Low risk , "The Article Title: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease Article Snippet: .. Low risk "The Sequencing:Article Title: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease Article Snippet: .. Low risk “The Article Title: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease Article Snippet: Randomised? , Low risk , "Treatment was assigned by the investigators with sequential study numbers according to a block randomisation list in ratios of 2:2:1 (Roflumilast 250 μg, Roflumilast 500 μg, Placebo).". .. Method of randomisation described? , Low risk , "The Article Title: Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease Article Snippet: .. Low risk "The other:Article Title: Ciclesonide versus other inhaled corticosteroids for chronic asthma in children Article Snippet: Dr. Renate Engelstatter is an employee of |
Guillaumier 2018 " width="250" height="auto" />
Holliday 2019 " width="100%" height="100%">
Skelton 2022 " width="100%" height="100%">